This bill prohibits United States persons from importing AI technology produced in the People’s Republic of China, exporting or transferring AI technology to or within China, and from conducting or transferring AI research that benefits Chinese entities of concern. It adds a new Chapter 124 to Title 18 that defines covered AI technology, identifies covered actors (including PRC universities, research labs, corporations, and government entities), and criminalizes a broad set of research, development, and transfer activities involving those actors.
The statute couples these operational bans with steep civil and criminal penalties, forfeiture of federal contracts and grants, a five‑year bar from federal financial assistance, and immigration consequences by treating violations as aggravated offenses for certain immigration provisions. It also bars U.S. persons from holding interests in or financing PRC entities engaged in AI R&D or associated with military‑civil fusion, and authorizes use of IEEPA powers for enforcement.
At a Glance
What It Does
The bill (1) bans importation into the U.S. and export/reexport or in‑country transfer of AI or generative AI technology to the People’s Republic of China; (2) creates a new federal offense forbidding U.S. persons from conducting R&D, collaborating, or transferring AI research to PRC entities of concern; and (3) prohibits U.S. persons from holding financial interests in or financing specified Chinese AI entities. It instructs Commerce and the Attorney General to issue implementing regulations.
Who It Affects
U.S. researchers, universities, corporations (including subsidiaries), investors and financial institutions with China exposure, technology hardware and cloud providers, and federal agencies charged with export control and immigration enforcement. The bill’s definition of 'United States person' explicitly covers institutions organized under U.S. law and lawful permanent residents.
Why It Matters
This statute would reframe U.S. AI policy from export‑control tailoring to an across‑the‑board decoupling approach—targeting both goods and activities, and combining criminal penalties, civil remedies, investment restrictions, and immigration consequences in one package. Compliance, contracting, and research governance practices across the private and academic sectors would need substantive revision.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill establishes three parallel tracks to restrict U.S. involvement in Chinese AI capabilities. First, it imposes an import ban (for AI technology developed in the PRC) and an export/reexport and in‑country transfer ban to the PRC, each effective 180 days after enactment, with Commerce required to issue implementing regulations within 90 days.
Violations of these trade prohibitions trigger criminal and civil penalties that mirror provisions of the Export Control Reform Act.
Second, the bill inserts a new Chapter 124 into Title 18. That chapter supplies a wide set of definitions for 'artificial intelligence' and 'generative artificial intelligence,' enumerates covered technology (explicitly listing chips, GPUs, TPUs, cloud services, and related hardware/software), and defines 'entity of concern' to include PRC universities, research labs, corporations, and government or Party entities.
It then makes it unlawful for a U.S. person to perform, attempt, conspire to perform, or assist in AI research or development within the PRC, for or with entities of concern, or to transfer research to or from such entities.Third, the bill attaches substantial penalties and remedial tools to Chapter 124: large fines (up to $100 million for corporate actors and $1 million for individuals), forfeiture of federal licenses and contracts, a five‑year bar on receiving federal financial assistance after a violation, and civil remedies providing equitable relief plus treble damages and recovery of litigation costs. The legislation also amends the Immigration and Nationality Act so that an offense under the new section is listed among aggravated offenses relevant to certain immigration consequences.Finally, a separate provision (effective one year after enactment) prohibits U.S. persons from knowingly holding or managing interests in, or lending to, Chinese entities of concern that conduct AI R&D, produce AI goods, support military‑civil fusion, enable surveillance capabilities, or are implicated in human‑rights abuses.
The President may use IEEPA authorities to implement and enforce that investment and financing bar, with penalties modeled on IEEPA’s enforcement provisions.
The Five Things You Need to Know
The import and export bans on AI technology to/from the PRC take effect 180 days after enactment, and the Secretary of Commerce must issue implementing regulations within 90 days.
Chapter 124 in Title 18 prohibits a U.S. person from conducting, aiding, or transferring AI research or development for, with, or on behalf of PRC 'entities of concern'—a category that expressly includes PRC universities, research labs, corporations, and government/Party entities (Hong Kong and Macau included).
Penalties for Chapter 124 violations include corporate fines up to $100 million, individual fines up to $1 million, forfeiture of federal licenses/contracts/grants, and ineligibility for federal financial assistance for five years.
The bill amends INA section 101(a)(43) to list an offense under the new Title 18 provision among crimes that carry immigration and naturalization consequences, potentially affecting lawful permanent residents and applicants.
One year after enactment, U.S. persons are prohibited from holding or managing interests in, or extending credit to, Chinese entities that do AI R&D or AI production tied to military‑civil fusion, surveillance, or human‑rights abuses, with enforcement authority drawn from IEEPA.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Names the measure the 'Decoupling America’s Artificial Intelligence Capabilities from China Act of 2025.' This is a standard placement; it does not affect substantive implementation but signals the legislative purpose—explicit decoupling of AI capabilities from the PRC.
Top‑level definitions and scope for import/export ban
Provides definitions referenced in the export/import prohibitions, and cross‑references additional definitions that the bill later adds to Title 18. Notably, it defines 'artificial intelligence or generative artificial intelligence technology or intellectual property' as anything that could contribute to AI capabilities, and borrows export terminology from the Export Control Reform Act of 2018, which frames the subsequent trade prohibitions and penalties.
Import and export prohibitions; Commerce rulemaking; penalties
Imposes two immediate trade controls: an import ban on AI technology developed or produced in the PRC and a ban on exports, reexports, and in‑country transfers of AI technology to or within the PRC; both start 180 days post‑enactment. The provision attaches criminal and civil penalties by reference to the Export Control Reform Act’s enforcement provisions and requires the Secretary of Commerce to promulgate implementing regulations within 90 days, placing urgency on Commerce to define covered goods, exceptions, licensing pathways, and enforcement mechanisms.
Definitions, prohibitions on R&D and transfers, penalties, and regulatory coordination
Adds a new chapter with lengthy, operational definitions of AI, generative AI, 'entity of concern,' 'United States person,' and the covered technology list (explicitly including semiconductors, GPUs, TPUs, FPGAs, memory, storage, cloud services, and related hardware/software). The chapter makes it a federal offense for U.S. persons to perform, attempt, conspire, or assist in AI research or development inside the PRC, for or with entities of concern, or to transfer AI research to or from them. Penalties for violation include substantial fines, forfeiture of federal benefits (licenses, contracts, grants), a five‑year bar on federal financial assistance, and civil remedies granting the United States treble damages plus equitable relief. The Attorney General is directed to consult multiple agencies to promulgate implementing regulations and to coordinate enforcement.
Immigration consequences tied to Title 18 offense
Amends the Immigration and Nationality Act’s list of crimes (section 101(a)(43)) to add offenses under the new section 2742. Practically, a conviction under the new Title 18 provision will be treated as an aggravated offense for purposes of certain immigration provisions—an explicit statutory link that raises deportation, inadmissibility, and naturalization consequences for covered offenders.
Investment and financing prohibition; IEEPA authority and penalties
Prohibits U.S. persons, beginning one year after enactment, from knowingly holding or managing interests in, or lending to, 'Chinese entities of concern' that conduct AI R&D or manufacture AI goods, and those implicated in military‑civil fusion, surveillance, or human‑rights abuses. The President may use powers under the International Emergency Economic Powers Act to implement this section. Violations are punished under IEEPA’s penalty framework, giving the executive branch strong economic enforcement tools separate from the Title 18 criminal/civil regime.
This bill is one of many.
Codify tracks hundreds of bills on Technology across all five countries.
Explore Technology in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- U.S. national security and defense agencies — The legislation narrows routes for technology and research transfer to PRC military and mixed civil‑military programs, aligning legal tools to prevent acquisition of U.S. AI advances that could be used for military or surveillance ends.
- Domestic AI hardware and software suppliers — By blocking PRC imports of AI components and restricting financing of Chinese AI producers, the bill could reduce competitive pressure from some PRC producers and redirect demand toward U.S. and allied suppliers.
- Communities and populations vulnerable to PRC‑enabled surveillance or human‑rights abuses — Restricting transfers and financing tied to surveillance and human‑rights flagged actors aims to reduce U.S.-derived contributions to abusive systems.
Who Bears the Cost
- U.S. research institutions and universities with PRC collaborations — The broad prohibition on research collaboration and transfers will force institutions to reassess partnerships, contractual clauses, data sharing, and visa sponsorship policies; compliance and licensing burdens will rise.
- Multinational corporations and cloud/hardware providers — Firms that operate development centers, cloud regions, or supply chains overlapping the PRC will face tough choices: restructure operations, exit markets, or risk significant fines and loss of federal contracts.
- Investors and financial institutions — The one‑year investment prohibition creates market risk for funds holding PRC AI equities or providing credit; wealth managers and pension funds will need new screening and divestment processes.
- Federal agencies and enforcement bodies — Commerce, DOJ, FBI, and the agencies named for regulatory coordination must implement complex regulations, conduct investigations, and manage interagency enforcement with little additional funding in the text, increasing administrative burdens.
- Individual researchers and lawful permanent residents — The criminal and immigration provisions mean that individuals can face fines, loss of federal benefits, and immigration consequences for conduct that under prior norms might have been academic collaboration.
Key Issues
The Core Tension
The central dilemma is national security versus openness and economic integration: stopping transfers that could enable PRC military and surveillance uses of AI requires sweeping prohibitions that simultaneously constrain academic collaboration, multinational operations, and investor choice—forcing policymakers to decide whether preventing potential future harms justifies large, immediate disruptions to research, commerce, and immigration outcomes.
The bill’s breadth and definitional reach create implementation and legal complexity. Its technology list explicitly includes chips, GPUs, cloud services, and many components, but also relies on expansive phrases—'could be used to contribute to AI capabilities' and systems that 'interact with humans'—which will force regulators to draw bright lines between ordinary academic work, dual‑use research, and covered activity.
Commerce and DOJ rulemaking will therefore be determinative: the 90‑day rulemaking window for Commerce on trade bans and the cross‑agency regulatory coordination directed to the Attorney General set tight timelines for complex technical determinations.
Second, the statute layers remedies from different legal regimes—export control penalties, Title 18 criminal fines, civil treble damages, forfeiture of federal contracts and grants, IEEPA enforcement for investment prohibitions, and immigration consequences tied to conviction. That mixture amplifies potential penalties but also risks overlapping or conflicting enforcement approaches between agencies, raises due‑process and proportionality questions (particularly for administrative forfeitures or long federal funding bars), and invites litigation over extraterritorial reach and constitutional claims (academic freedom, due process, and equal protection arguments could be raised).
Finally, the bill trades one national policy objective—restricting technology transfer to actors tied to the PRC military or abusive surveillance—for collateral impacts on open science, global research ecosystems, U.S. industry competitiveness, and international research standards. The statute effectively forces firms and institutions to choose between market access and compliance with U.S. national security priorities; how regulators calibrate exceptions, licensing pathways, or carve‑outs (none are detailed in the text) will determine whether the bill fractures research collaborations or creates workable compliance channels.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.